A new test ovarian cancer

At Yale University scientists has developed a new technique for early diagnosis of ovarian cancer.
Test allows diagnose cancer with an accuracy of 99%, said LookInfo.org.ua.
According to the head of research Gil Mor, the test determines the concentration of the six-protein biomarkers in a small number of blood serum (effect lexapro side, phentermine texas), which are considered among the proteins produced a body in response to the tumor or tumor itself produced.

Tests, which have been used before, to ensure the accuracy of such a diagnosis is not more than 15-20% of cases. These techniques were based only on determining the existence of tumor protein (asthma ibuprofen, is propecia safe).

The second phase of clinical trials covered 500 people, of whom 150 have been diagnosed with ovarian cancer. The results obtained in the course of the new test, in addition to themselves researchers also evaluated by independent experts from the National Cancer Institute of USA.

To date, scientists under the direction of Mora already under a third phase of testing the test (hydrocodone abuse, 20 lexapro mg), which is a S.pneumoniae clinical study involving 2000 patients.

According to Gil Mor - "We hope that this test would be one of the standard medical tests(estradiol side effects, celebrex alert), in a survey of women appointees."

Cancer ovaries was one of the causes of death among women of oncological diseases. This disease is sometimes called "quiet killer" because of his long period of not accompanied by any symptoms (cheap bontril online, article on celebrex), and in most cases have already been detected only at the terminal, late stages.